Lisdexamfetamine is a central nervous system (CNS) stimulant used to treat attention deficit hyperactivity disorder (ADHD) in adults and children over 6 years of age and moderate to severe eating disorders.
Use and indications
Lisdexamfetamine is most commonly used to treat ADHD in children between 6 and 18 years of age. However, if well tolerated and indicated, use beyond this age is possible. In some countries, lisdexamfetamine is only indicated if previous therapy with the active ingredient methylphenidate (Ritalin, Medikinet, etc.) has not been effective. In many countries, however, it can also be used as a "first-line therapeutic". In addition, it can be used to treat so-called binge-eating disorder, an eating disorder. This involves reducing the number of binge eating episodes in affected patients.
The active ingredient is administered in the form of raked capsules and is available in doses of 30 mg, 50 mg, and 70 mg. The dosage depends on the patient's weight. Lisdexamfetamine can also be given in the form of chewable tablets.
Lisdexamfetamine was first approved for medical use in the United States in 2007. It was developed and patented by Takeda Pharmaceutical.